NCT03602898 2021-06-30Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationFred Hutchinson Cancer CenterPhase 2 Withdrawn
NCT03438344 2018-11-21Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantCity of Hope Medical CenterPhase 2 Withdrawn
NCT01652014 2016-07-14Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesRutgers, The State University of New JerseyPhase 2 Withdrawn
NCT00301912 2012-10-02Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerUniversity of California, San FranciscoPhase 2 Withdrawn